Songjiang Ma, President at GYRE THERAPEUTICS, INC. (GYRE), sold 174 shares at $10.00 ($2K) on 2025-03-21, disclosed to the SEC on 2025-03-25.
Scheduled sale ($2k) by President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| GYRE | SELL | 2025-05-22 | $44K | — | Filing → |
| GYRE | SELL | 2025-05-20 | $45K | — | Filing → |
| GYRE | SELL | 2025-05-16 | $22K | — | Filing → |